1. Home
  2. BEAM vs CXM Comparison

BEAM vs CXM Comparison

Compare BEAM & CXM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BEAM
  • CXM
  • Stock Information
  • Founded
  • BEAM 2017
  • CXM 2009
  • Country
  • BEAM United States
  • CXM United States
  • Employees
  • BEAM N/A
  • CXM N/A
  • Industry
  • BEAM Biotechnology: Biological Products (No Diagnostic Substances)
  • CXM Computer Software: Prepackaged Software
  • Sector
  • BEAM Health Care
  • CXM Technology
  • Exchange
  • BEAM Nasdaq
  • CXM Nasdaq
  • Market Cap
  • BEAM 1.9B
  • CXM 2.3B
  • IPO Year
  • BEAM 2020
  • CXM 2021
  • Fundamental
  • Price
  • BEAM $29.01
  • CXM $9.11
  • Analyst Decision
  • BEAM Buy
  • CXM Hold
  • Analyst Count
  • BEAM 10
  • CXM 15
  • Target Price
  • BEAM $47.67
  • CXM $9.89
  • AVG Volume (30 Days)
  • BEAM 1.2M
  • CXM 3.4M
  • Earning Date
  • BEAM 11-05-2024
  • CXM 12-04-2024
  • Dividend Yield
  • BEAM N/A
  • CXM N/A
  • EPS Growth
  • BEAM N/A
  • CXM 36.57
  • EPS
  • BEAM N/A
  • CXM 0.15
  • Revenue
  • BEAM $349,643,000.00
  • CXM $788,062,000.00
  • Revenue This Year
  • BEAM N/A
  • CXM $9.47
  • Revenue Next Year
  • BEAM $10.82
  • CXM $3.63
  • P/E Ratio
  • BEAM N/A
  • CXM $60.11
  • Revenue Growth
  • BEAM 328.73
  • CXM 12.02
  • 52 Week Low
  • BEAM $20.84
  • CXM $6.91
  • 52 Week High
  • BEAM $49.50
  • CXM $14.32
  • Technical
  • Relative Strength Index (RSI)
  • BEAM 56.94
  • CXM 61.13
  • Support Level
  • BEAM $24.96
  • CXM $8.81
  • Resistance Level
  • BEAM $29.53
  • CXM $9.47
  • Average True Range (ATR)
  • BEAM 2.05
  • CXM 0.40
  • MACD
  • BEAM -0.04
  • CXM -0.01
  • Stochastic Oscillator
  • BEAM 67.05
  • CXM 73.18

About BEAM Beam Therapeutics Inc.

Beam Therapeutics Inc is a biotechnology company engaged in creating genetic medicines based on its base editing technology. This technology enables a new class of genetic medicines that targets a single base in the genome without making a double-stranded break in the DNA. The company's portfolio comprises Gene Correction, Gene Modification, Gene Activation, Gene Silencing, and Multiplex Editing. The company's pipeline programs consist of BEAM-101, ESCAPE, BEAM-302, BEAM-301, and BEAM-201.

About CXM Sprinklr Inc.

Sprinklr Inc is engaged in providing enterprise software that enables every customer-facing function across the front office, from Customer Care to Marketing, to collaborate across internal silos, and communicate across digital channels. Its products include Sprinklr Service, Sprinklr Social, Sprinklr Insights and Sprinklr Marketing. The company operates in Americas, EMEA and other countries. It derives maximum revenue from Americas.

Share on Social Networks: